ACRS- Aclaris Therapeutics, Inc.

Name: Aclaris Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Aclaris Therapeutics, Inc. (ACRS) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. ACRS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Leonard Braden Michael	13.95M	$62.77M	-
Other	Kolbeck Roland Wilhelm	510.0K	$2.29M	-
COO	Davis Hugh M.	336.3K	$1.51M	-
CEO	Walker Neal	274.8K	$1.24M	-
Other	Loerop James	18.7K	$84.2K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Feb 15, 2023	Monahan Joseph87	Chief Scientific Officer	Sell	5,000	$13.06	$65,310.50	-5.2%	-37.5%	-90.6%
Feb 8, 2023	Loerop James	Chief Business Officer	Sell	4,267	$13.89	$59,272.47	-37.9%	-39.7%	-91.4%
Feb 2, 2023	Walker Neal85	Director	Sell	30,000	$16.66	$499,922.79	-0.5%	-37.2%	-91.6%
Jan 4, 2023	Walker Neal85	Director	Sell	40,000	$15.11	$604,555.77	-1.1%	-42.1%	-92.7%
Dec 15, 2022	Monahan Joseph87	Chief Scientific Officer	Sell	5,000	$15.88	$79,411.50	-4.9%	-48.9%	-93.5%
Nov 14, 2022	Schiff Andrew N84	Director	Sell	53,926	$17.05	$919,589.25	-3.8%	-22.4%	-96.1%
Oct 26, 2022	Schiff Andrew N84	Director	Sell	41,174	$17.01	$700,355.02	-2.7%	-0.5%	-72.2%
Oct 18, 2022	Schiff Andrew N84	Director	Sell	52,037	$16.57	$862,109.13	-4.6%	+5.3%	-68.9%
Oct 17, 2022	Monahan Joseph87	Chief Scientific Officer	Sell	5,000	$15.98	$79,907.50	-4.7%	+11.2%	-65.7%
Oct 7, 2022	Schiff Andrew N84	Director	Sell	7,324	$16.16	$118,349.25	-1.2%	-3.7%	-61.7%

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC